Noxopharm Market Cap

Noxopharm has a market cap or net worth of 24.58 million as of April 29, 2026. Its market cap has increased by 16.81% in one year.

Market Cap

24.58M

Enterprise Value

28.73M

Revenue

3.40M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.08

Market Cap Chart

Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 24.58M, an increase of 76.74%. That is a compound annual growth rate of 6.03%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	24.58M	-9.56%
Dec 31, 2025	27.18M	-
Dec 31, 2024	27.18M	30.99%
Dec 29, 2023	20.75M	-51.03%
Dec 30, 2022	42.37M	-62.82%
Dec 31, 2021	113.97M	-9.32%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Algorae Pharmaceuticals	22.25M
Argenica Therapeutics	21.84M
Patrys	17.13M
Neurotech International	17.13M
EZZ Life Science Holdings	35.54M
NeuroScientific Biopharmaceuticals	38.25M
Avecho Biotechnology	40.41M
Imugene	44.63M

Market Cap Rankings